Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000116

EVP, Chief Commercial Officer sold 4,910 shares at an average $487.65 ($2,394,365)

  • EVP, Chief Commercial Officer gave up 873 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

McKechnie Duncan · EVP, Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-24 Shares withheld for taxes : show line 1 in the form 10b5-1 −873 $485.11 $423,501 22,469 D
2026-02-25 Sale : show line 2 in the form 10b5-1 −2,500 $486.35 $1,215,875 19,969 D
2026-02-25 Sale : show line 3 in the form 10b5-1 −2,410 $489.00 $1,178,490 17,559 D
Open-market sales · 4,910 sh · avg $487.65 · $2,394,365
Loading xslF345X05/wk-form4_1772149699.xml…